Malabre Richard C 4
4 · Akebia Therapeutics, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
Malabre Richard C
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-06-04$3.53/sh−13,334$47,069→ 266,914 total
Footnotes (2)
- [F1]This sale was made pursuant to a Rule 10b5-1 Non-Discretionary Option Exercise and Stock Sale Plan adopted by the Reporting Person on December 12, 2024.
- [F2]The shares were sold at prices ranging from $3.50 to $3.60 and the price reported reflects the weighted average sale price.